A Study to Compare Tenofovir DF Versus the Combination of Emtricitabine Plus Tenofovir DF for the Treatment of Chronic Hepatitis B in Patients With Normal Alanine Aminotransferase (ALT)
Clinical trial NCT00507507 · COMPLETED
Trial details
- NCT number
- NCT00507507
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2012-02-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.